CAMBRIDGE, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (RLAY) (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback